Enanta Pharmaceuticals raises $56 million in IPO

Published



Enanta Pharmaceuticals Inc. raised $56 million in an initial public offering of 4 million shares after the drug developer priced the stock at $14 per share, which was at the low end of its expected range.

Shares will start trading Thursday under the ticker symbol ENTA on the Nasdaq stock market.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.